Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Smoldering multiple myeloma: a multi-country mixed-methods study on disease perceptions and patient treatment preferences.
Journal: Future oncology (London, England)
Published: August 04, 2026
Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma.
Journal: The New England journal of medicine
Published: December 09, 2024
Real-world characteristics and outcomes of patients with high-risk and non-high-risk smoldering multiple myeloma using the Flatiron Health database.
Journal: Blood cancer journal
Published: March 29, 2024
Blinatumomab versus historical standard therapy in pediatric patients with relapsed/refractory Ph-negative B-cell precursor acute lymphoblastic leukemia.
Journal: Leukemia
Published: September 06, 2019
Results from an international phase 2 study of the anti-CD22 immunotoxin moxetumomab pasudotox in relapsed or refractory childhood B-lineage acute lymphoblastic leukemia.
Journal: Pediatric blood & cancer
Published: July 19, 2019
Decitabine and Vorinostat with Chemotherapy in Relapsed Pediatric Acute Lymphoblastic Leukemia: A TACL Pilot Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 16, 2019
Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia & lymphoma study.
Journal: Leukemia
Published: October 20, 2017
The Effects of Hospital Length of Stay on Readmissions for Children With Newly Diagnosed Acute Lymphoblastic Leukemia.
Journal: Journal of pediatric hematology/oncology
Published: March 19, 2016
Showing 1-10 of 10
Last Updated: 09/26/2026